Search Browse Earnings

BIOCEPT INC — SlamSEC

BIOCEPT INC

Services-Medical Laboratories·SAN DIEGO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$61.2M

+123.0% YoY

FY 2022

Adj. EBITDA

-$879,000

-1.4% margin

FY 2022

Net Income

-$2.8M

-4.6% margin

FY 2022

EPS (Diluted)

-$0.19

FY 2022

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$69,178

FY 2015

Total Debt

$10.0M

FY 2014

Net Debt

$9.9M

FY 2014

Enterprise Value

—

Debt / EBITDA

-11.2x

FY 2022

EV / EBITDA

—

Employees

—